A comparison of adherence rates to ritonavir (soft-gel capsules) and its accompanying protease inhibitor (PI) in patients receiving ritonavir boosted PI regimens

Trial Profile

A comparison of adherence rates to ritonavir (soft-gel capsules) and its accompanying protease inhibitor (PI) in patients receiving ritonavir boosted PI regimens

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 10 Nov 2009

At a glance

  • Drugs HIV protease inhibitors; Ritonavir
  • Indications HIV infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 10 Nov 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 17 Mar 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top